Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Humanin

HN, S14G-Humanin

Quick Stats
Studies 491
Trials 100
Score 2
2016 pubmed 53 citations

Humanin Protects RPE Cells from Endoplasmic Reticulum Stress-Induced Apoptosis by Upregulation of Mitochondrial Glutathione.

Matsunaga. Douglas D; Sreekumar. Parameswaran G PG; Ishikawa. Keijiro K; Terasaki. Hiroto H; Barron. Ernesto E; Cohen. Pinchas P; Kannan. Ram R; Hinton. David R DR

Key Findings

  • Humanin dose‑dependently reduces ER‑stress‑induced apoptosis in retinal pigment epithelium cells
  • It lowers mitochondrial superoxide and restores mitochondrial glutathione levels
  • Humanin also cuts activation of stress‑related caspases (3 and 4) in these cells

Practical Outcomes

  • Humanin looks promising as a cellular protectant against ER stress, which is linked to eye and neuro‑degenerative issues. However, there’s no human dosing guidance yet, so biohackers should treat it as a research lead rather than a ready‑to‑use supplement. If interested, watch for clinical trials or validated oral analogs before adding it to a protocol.

Summary

The study shows that the tiny protein humanin can shield eye‑cell and brain‑cell models from death caused by stress in the cell’s protein‑making factory, mainly by boosting a key antioxidant inside mitochondria. It works better at higher doses in the lab, but the work is still only in petri dishes, not people.

Abstract

Humanin (HN) is a small mitochondrial-encoded peptide with neuroprotective properties. We have recently shown protection of retinal pigmented epithelium (RPE) cells by HN in oxidative stress; however, the effect of HN on endoplasmic reticulum (ER) stress has not been evaluated in any cell type. Our aim here was to study the effect of HN on ER stress-induced apoptosis in RPE cells with a specific focus on ER-mitochondrial cross-talk. Dose dependent effects of ER stressors (tunicamycin (TM), brefeldin A, and thapsigargin) were studied after 12 hr of treatment in confluent primary human RPE cells with or without 12 hr of HN pretreatment (1-20 μg/mL). All three ER stressors induced RPE cell apoptosis in a dose dependent manner. HN pretreatment significantly decreased the number of apoptotic cells with all three ER stressors in a dose dependent manner. HN pretreatment similarly protected U-251 glioma cells from TM-induced apoptosis in a dose dependent manner. HN pretreatment significantly attenuated activation of caspase 3 and ER stress-specific caspase 4 induced by TM. TM treatment increased mitochondrial superoxide production, and HN co-treatment resulted in a decrease in mitochondrial superoxide compared to TM treatment alone. We further showed that depleted mitochondrial glutathione (GSH) levels induced by TM were restored with HN co-treatment. No significant changes were found for the expression of several antioxidant enzymes between TM and TM plus HN groups except for the expression of glutamylcysteine ligase catalytic subunit (GCLC), the rate limiting enzyme required for GSH biosynthesis, which is upregulated with TM and TM+HN treatment. These results demonstrate that ER stress promotes mitochondrial alterations in RPE that lead to apoptosis. We further show that HN has a protective effect against ER stress-induced apoptosis by restoring mitochondrial GSH. Thus, HN should be further evaluated for its therapeutic potential in disorders linked to ER stress.

Study Information

Provider

pubmed

Year

2016

Date

2016-10-26T00:00:00.000Z

DOI

10.1371/journal.pone.0165150

Citations

53

References

65